Skip Ribbon Commands
Skip to main content

​​​​​​​

​​

Primary Diagnosis

Type 2 Diabetes

Study Purpose

To assess whether treatment with permafibrate will prevent myocardial infarction, ischemic stroke, unstable angina, and cardiovascular death in adults with Type 2 Diabetes Mellitus.

Principal Investigator: Marcus McKenzie, MD

Trial Details

Locations: Legacy Heart Center Plano

Sponsor: Kowa Research Institute

IRB Number: 017-488

Trial Status: Enrolling

Exclusions: Adults only

Change in Care: Participating will ​change your care

Contact Information:

Alexandria Biberstein, RN
469.814.4732
Alexandria.Biberstein@BSWHealth.org

Full Protocol Title

Permafibrate to reduce cardiovascular outcomes by reducing triglycerides in patients with diabetes.

Get Detailed Infor​mation O​n Clin​icaltrials.gov »​​​​​​​​​​​​​​​​​​​​​​​​

​​

​​

​​​​​​​​​​BAYLOR SCOTT & WHITE RESEARCH ​INSTITUTE​​